Deal overview
| Target | PRINCIPIA BIOPHARMA INC |
|---|---|
| Bidder | SANOFI SA |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | Aug 17, 2020 |
| Abstract | On 17 August 2020, the quoted French pharmaceutical company Sanofi SA ("Sanofi") announced a recommended cash offer for Principia Biopharma Inc ("Principia"), a Nasdaq listed biopharmaceutical company. The offer of $100 per share represented an aggregate equity value of approximately $3.68 billion (on a fully diluted basis). The offer was expected to commence later that ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
